Navigation Links
Bradmer sponsors physician panel to raise awareness of brain cancer treatments
Date:11/5/2008

h completed trial. Neuradiab has been formerly referred to in literature as 131-I anti-tenascin monoclonal antibody 81c6.

GBM tumors typically have infiltrating edges that are very difficult to completely remove with surgery. The Neuradiab therapy is delivered directly into the surgical resection cavity in a separate procedure after the initial surgery. Neuradiab delivers a concentrated level of radiation specifically to the remaining cancer cells by targeting tenascin. Tenascin is a protein over-expressed in 99% of GBM cells but absent from normal brain cells.

About Bradmer Pharmaceuticals Inc. (http://www.bradmerpharma.com)

Bradmer Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of new and innovative cancer therapies. Bradmer's lead clinical candidate, Neuradiab, was developed at Duke University Medical Center as a proprietary therapy for a particularly aggressive form of brain cancer, glioblastoma multiforme. Bradmer has initiated enrollment in a Phase III multi-center clinical trial of the licensed treatment. Neuradiab has been granted Orphan Drug Status by both the U.S. Food and Drug Administration and the European Medicines Agency.

Bradmer Pharmaceuticals Inc.'s common shares have not been registered under the Securities Act of 1933, as amended (the "Securities Act") or any state regulatory agency in the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of Rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws.

Except for historical information, this press release may contain forward-looking statements, which reflect the Company's current expectation regarding future events. These forward-looking statements involve risk and uncertainties, which may cau
'/>"/>

SOURCE Bradmer Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. The MathWorks Sponsors iGEM Competition for Synthetic Biology at MIT : MATLAB and SimBiology Help Accelerate Design of Synthetic Biological Systems
2. InVitria Sponsors Cambridge Healthtechs Optimizing Cell Culture Development Conference
3. TCN e-Systems Offers Trial Sponsors Solutions for Creating In-House Center of Excellence in Patient Recruitment
4. BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008
5. Diplomat Specialty Pharmacy Sponsors National Managed Care Roundtable for Industry Executive Advisory Board
6. Baxa Announces Colorado BioScience Association Sponsorship
7. Varian Medical Systems Sponsors Special Broadcast of The Group Room(R), a Live Radio Talkshow About Cancer
8. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
9. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
10. iMedica Partners With LDM GROUP to Offer ScriptGuide to Physician Practice Customers
11. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... England , January 15, 2014 A ... win races on the Formula 1 track could help to ... McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based in ... by healthcare provider Simplyhealth. Telemetry technology, which is ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 Freeslate, ... solutions, today announced that Lupin Limited, one of India’s ... CM Protégé PharmD System for high throughput ... India, is focused on a wide range of quality, ...
(Date:1/14/2014)... Date: Friday, April 11, 2014 , Time: 6 p.m. ... Road, Warrington, Pa. , Details: The Hepatitis B ... a cure for hepatitis B and improving the quality of ... Ball on Friday, April 11 at Warrington Country Club in ...
Breaking Biology Technology:Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2
... Nov. 21 Trubion Pharmaceuticals Inc.,(Nasdaq: TRBN ... chief,executive officer and chairman of Trubion, is scheduled ... Capital Markets Healthcare Investor,Conference to be held at ... to present Nov. 27, 2007, at 2:30 p.m. ...
... Michele,Garufi, Chairman and CEO of NicOx (Eurolist: COX), will ... and development programs and the,status of ongoing alliances at ... November 26, 2007:, - At the 19th Annual ... US Eastern Time (21:00 Central European Time - 20:00 ...
... Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today that the company ... Grey, president & chief,executive officer of SGX Pharmaceuticals, will provide ... as follows:, -- 19th Annual Piper Jaffray Health ... 2007 at 11:30 AM Eastern Standard Time at The Pierre ...
Cached Biology Technology:Trubion Pharmaceuticals to Present at the Lazard Capital Markets Healthcare Investor Conference 2NicOx to Present at Financial Conferences in New York on November 27, 28 and 29 2SGX Pharmaceuticals to Present at Two Upcoming Investor Conferences 2
(Date:4/23/2014)... ripping open a dinner roll, a fuel cell catalyst ... hydrogen molecule. Now researchers have captured a view of ... its hydrogen feast. The view confirms previous hypotheses and ... better for alternative energy uses. , This study is ... hydrogen halves end up in the structure of a ...
(Date:4/23/2014)... of a unique rhythmic sound, recorded for decades in ... Antarctic minke whale ( Balaenoptera bonaerensis ). First described ... thought it sounded like a duck, the bio-duck sound ... Ocean, but its source has remained a mystery, until ... researchers deployed acoustic tags on two Antarctic minke whales ...
(Date:4/23/2014)... Buenos Aires yesterday, Argentina joins the European Molecular ... The move strengthens the ties between the European ... Argentinian scientists access to EMBL,s world-class facilities and ... since its inception, fostering excellent life science research ... core of EMBL,s mission," says EMBL Director General ...
Breaking Biology News(10 mins):Halving hydrogen 2Halving hydrogen 3Halving hydrogen 4Scientists identify source of mysterious sound in the Southern Ocean 2Scientists identify source of mysterious sound in the Southern Ocean 3
... believe the scientific consensus on global warming more than ... University researcher. The findings, published in the September ... challenge common perceptions that men are more scientifically literate, ... claim they have a better understanding of global warming ...
... Washington State University researchers have discovered the mechanism by which ... The finding clears the way for a suite of discoveries, ... injuries. "We know that brain activity is linked to ... neuroscientist and lead author of a paper in the latest ...
... and crises are related to each other by more than ... For example, earthquakes, homicide surges, magnetic storms, and the U.S. ... a theoretical framework presented in the journal CHAOS , ... The researchers who developed this framework contend that these four ...
Cached Biology News:Women more likely than men to accept global warming 2WSU researchers discover key mechanism behind sleep 2Improving crisis prediction, disaster control and damage reduction 2